Investors

OvaScience is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility.

OVAS (Common Stock)
Price & Exchange
$21.38
NASDAQ
Change (%)
 Stock is Up 0.55 (2.64%)
Volume
764,058
08/27/15      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Webcast ImageOn Demand Presentation
Overview of AUGMENTSM Treatment Patient Experience

Recent News

More »
DateTitle 
08/26/15Publication of OvaScience’s AUGMENT Fertility Treatment Shows Statistically Significant Improvements in Embryo Selection and Transfer Compared to Standard IVF
Real-World Experience from International IVF Clinics Reported in Peer-Reviewed Journal CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 26, 2015-- OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today the first published analysis of real-world patient experience comparing the AUGMENTSM fertility treatment to standard in vitro fertilization (IVF). In ... 
Printer Friendly Version
08/10/15Improved Pregnancy Rates and Healthy Births with OvaScience’s AUGMENT Fertility Treatment to be Published in Peer-Reviewed Journal
- New Analysis Shows Statistically Significant Higher Rates of Ongoing Pregnancies when Eggs from the Same Woman are Treated with AUGMENT Treatment versus Standard IVF Alone - - Higher Rate of Embryo Transfer with AUGMENT Treatment Based on Standard Embryo Quality Measures - - Company to Hold Business Update Call on August 11 at 7:00 AM ET - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 10, 2015-- OvaScienceSM (NASDAQ: OVAS), a globa... 
Printer Friendly Version
08/10/15OvaScience Reports Second Quarter 2015 Financial Results
- Healthy Babies Born with AUGMENT Fertility Treatment; IVF Clinics in New International Regions Offer AUGMENT Treatment - - 2015 Plans for OvaPrime and OvaTure Treatments on Track - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 10, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported second quarter 2015 financial results and highli... 
Printer Friendly Version
08/06/15OvaScience Expands AUGMENT℠ Fertility Treatment Offering through IVI Group, the Largest IVF Clinic Network in the World
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 6, 2015-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that the AUGMENTSM fertility treatment will be introduced to patients at IVI Valencia, a clinic within the IVI Group of 38 in vitro fertilization (IVF) clinics spanning nine countries in Europe, North America, South America and Asia. The AUGME... 
Printer Friendly Version

Upcoming Events

More »
DateTitle
09/08/15
through
09/10/15
Ovascience Inc at H.C. Wainwright/Rodman & Renshaw Global Investment Conference
LocationNew York, NY
09/29/15
Ovascience Inc at Ladenburg Thalmann Healthcare Conference
LocationNew York, NY
Powered by Thomson Reuters
Data Provided by Thomson Reuters
Minimum 20 minutes delayed